Cohort News

Background Extravascular implantable cardioverter-defibrillators (EV-ICDs) are being developed to overcome limitations of current implantable cardioverter-defibrillators (ICDs). The AtaCor parasternal EV-ICD system uses an extravascular lead along the left parasternum to deliver defibrillation and pacing therapy from outside the heart. Objective... Read More →

Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System® NEW YORK & CHICAGO–(BUSINESS WIRE)–VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced it has entered into... Read More →

WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company’s cardiovascular intelligence software platform designed for high-risk surgical... Read More →

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ — InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, including varicose veins.... Read More →

In this episode of the Crux of Cardio, host Jordan Bergen sits down with Filip Peters, Co-founder and CEO of Acorai, to unpack how his team is building a non-invasive device that reads the pressures inside the heart, using machine... Read More →

PERTH, Australia–(BUSINESS WIRE)–OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™. The Funding round included a cornerstone investment... Read More →

How emerging research and advanced reproductive tools help producers identify high-influence sires and improve herd reproductive outcomes. Tools such as EmVision created by EmGenisys now provide producers with a way to assess embryo viability more precisely. Using video analysis and... Read More →

DETROIT, Feb. 11, 2026 (GLOBE NEWSWIRE) — Entirety Biomedical, a Michigan-based medical device startup developing bioabsorbable implant systems with its proprietary Curasorb technology, today announced the closing of a $1.2 million Seed financing round to advance toward first-in-human clinical trials.... Read More →

Patient Struggled with SNM Battery Pain and Complications; Reports Full Complication Relief Following Implant of Neuspera’s SNM Therapy New Patient Registry to Track Outcomes of SNM to iSNM Procedures SAN JOSE, Calif., Feb. 10, 2026 /PRNewswire/ — Neuspera® Medical, Inc.,... Read More →

Certification reinforces Plexāā’s commitment to quality excellence, ensuring safe, reliable Prehab™ devices and improved patient outcomes. Los Angeles, CA — February 9, 2026 — Plexāā Ltd., a brand-new Prehab™ tech platform revolutionizing the underserved pre-op phase, announces it has achieved... Read More →